FABP4 and myeloid sarcoma: FABP4 levels are increased in overweight and obese subjects compared with those in lean subjects, and several pathologies have been linked to adipose tissue dysfunction, such as MS, type-2 diabetes, atherogenic dyslipidemia, human immunodeficiency-virus associated lipodystrophy, and polycystic ovary syndrome[10-14].